What Researchers Did
Researchers studied how quickly carboxyhemoglobin levels dropped in adult patients with carbon monoxide poisoning who were treated with high flow nasal cannula oxygen.
What They Found
In 33 patients, the average carboxyhemoglobin half-life was 36.8 minutes when treated with high flow nasal cannula oxygen. Carboxyhemoglobin levels were cut in half within the first 40 minutes for 22 (67%) of the patients. Most patients (20 out of 33) found the high flow nasal cannula comfortable, with only 11 requesting flow rate adjustments.
What This Means for Canadian Patients
For Canadian patients experiencing carbon monoxide poisoning, this study suggests that high flow nasal cannula oxygen therapy can quickly reduce harmful carboxyhemoglobin levels. This method may offer a comfortable and effective initial treatment, potentially before or in conjunction with other therapies like hyperbaric oxygen, which is also used for severe cases.
Canadian Relevance
This study covers carbon monoxide poisoning, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
The study did not directly compare high flow nasal cannula oxygen therapy to other established treatments for carbon monoxide poisoning, such as hyperbaric oxygen therapy or standard non-rebreather masks.